Results 11 to 20 of about 20,430,225 (174)

Clear Cell and Non-Clear Cell Hepatocellular Carcinoma: A Case Report and Literature Review

Kaohsiung Journal of Medical Sciences, 2004
Clear cell hepatocellular carcinoma (HCC) is an uncommon variant of HCC. It is considered to have a better prognosis than non-clear cell HCC, but recent large studies show that there is some controversy.
Jenn-Hwa Liu, Huey-Ling Tsai
doaj   +5 more sources

Characteristics and Treatment Challenges of Non-Clear Cell Renal Cell Carcinoma [PDF]

Cancers, 2021
Non-clear cell renal cell carcinomas (RCC) comprise several rare and poorly described diseases, often characterized by bad prognosis and with no standard treatments available. The gap in their clinical management is linked to the poor molecular characterization in handling the treatment of non clear-cell RCC with untailored therapies.
Pierangela Sepe, Arianna Ottini, Chiara Carlotta Pircher, Andrea Franza, Melanie Claps, Valentina Guadalupi, Elena Verzoni, Giuseppe Procopio   +7 more
openaire   +3 more sources

Systemic Therapy for Non–Clear Cell Renal Cell Carcinoma

American Society of Clinical Oncology Educational Book, 2017
Treatment options for metastatic clear cell renal cell carcinoma (ccRCC) have evolved markedly over the past decade, with multiple targeted therapies approved for the disease. In contrast, little improvement has been made in the management of metastatic non–clear cell RCC (nccRCC).
Tian, Zhang, Jun, Gong, Manuel Caitano, Maia, Sumanta K, Pal   +3 more
core   +5 more sources

Therapeutic approaches in clear cell and non-clear cell renal cell carcinoma

Acta Clinica Belgica, 2016
Renal cell carcinoma (RCC) accounts for 2.4% of all malignancies worldwide diagnosed with 338,000 estimated new cases globally in 2012. In the last decade, the therapeutic landscape for RCC patients has changed tremendously. In this review, we will summarize the treatment options currently available for clear-cell localized, advanced and metastatic RCC
T, Vermassen, A, De Meulenaere, M, Van de Walle, Sylvie, Rottey   +3 more
openaire   +3 more sources

Advanced Treatments in Non-Clear Renal Cell Carcinoma

Urology Journal, 2011
PURPOSE: To focus on the use of targeted therapies against the non-clear histologic subtypes of renal cell carcinoma (RCC); papillary I and II, chromophobe, and collecting duct.
Hassan Errihani, Hind M’Rabti, Mohamed Fadl Tazi, Youness Ahellal, Ismail Essadi, El Mehdi Tazi   +5 more
doaj   +3 more sources

Survival Outcomes Between Clear Cell and Non-Clear Cell Epithelial Ovarian Cancer [PDF]

Thai Journal of Obstetrics and Gynaecology, 2013
Objective: To compare the 5-year survival rates of women with clear cell (CCC) versus those with non-clear cell (non-CCC) epithelial ovarian cancer.Materials and Methods: Retrospective study was performed on patients with epithelial ovarian cancer who ...
Wasanai Jermsirisakpong, Suphet Tuipae
doaj   +1 more source

Non-Clear Cell Renal Cell Carcinoma: Current Management and Best Practice

Kidney Cancer, 2017
The treatment of metastatic renal cell carcinoma (mRCC) has evolved markedly over the past several decades; first with the introduction of targeted therapies and more recently with data supporting checkpoint inhibition.
Meghan Salgia, Jacob Adashek, Paulo Bergerot, Sumanta K. Pal   +3 more
doaj   +4 more sources

Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma [PDF]

Journal for ImmunoTherapy of Cancer, 2018
Background Nivolumab is approved for patients with metastatic renal cell carcinoma (mRCC) refractory to prior antiangiogenic therapy. The clinical activity of nivolumab in patients with non-clear cell RCC subtypes remains unknown as these patients were ...
Vadim S. Koshkin, Pedro C. Barata, Tian Zhang, Daniel J. George, Michael B. Atkins, William J. Kelly, Nicholas J. Vogelzang, Sumanta K. Pal, JoAnn Hsu, Leonard J. Appleman, Moshe C. Ornstein, Timothy Gilligan, Petros Grivas, Jorge A. Garcia, Brian I. Rini   +14 more
doaj   +3 more sources

Evaluation of the Relative Enhancement Ratio and Morphologic Findings on Biphasic CT to Differentiate Clear Cell and Non-Clear Cell Renal Cell Carcinoma [PDF]

Siriraj Medical Journal, 2016
Objective: To differentiate clear cell and non-clear cell renal cell carcinoma (RCC) using enhancement pattern, relative enhancement ratio and associated findings on CT scan.
Nithida Na Songkhla
doaj   +3 more sources

Prognosis and Therapies in Non-Clear Cell Renal Cell Carcinomas. [PDF]

Cancers (Basel)
Background/Objectives: Non-clear cell renal cell carcinoma (nccRCC) comprises biologically heterogeneous renal malignancies with distinct molecular drivers, clinical behavior, and therapeutic responses. This review summarizes prognosis and systemic therapy and evaluates emerging histology-specific and biomarker-directed approaches. Methods: We analyzed
Shrivastava T, Medik Y, Kumar NS, Tu SM, Kunthur A.   +4 more
europepmc   +2 more sources